George Prendergast

George C. Prendergast, PhD

Resident Faculty
President and CEO

Research interests include: Molecular and Cellular Biology of Cancer, Cancer Immunology, Drug Discovery and Development

  • 2004–Present: Professor, President and CEO, Lankenau Institute for Medical Research
  • 2006–Present: Professor, Department of Pathology, Anatomy and Cell Biology, Sidney Kimmel College of Medicine, Thomas Jefferson University
  • 2006–Present: Co-director: Program in Cell Biology and Signaling, Sidney Kimmel Cancer Center, Thomas Jefferson University
  • 2010–2017: Editor-in-Chief, Cancer Research

George Prendergast, PhD, introduces the work of LIMR investigators and discusses the Institute’s unique over-arching imperative to create new therapies and biomedical advances to improve patient care.